Analysis of a p53 mutation associated with cancer susceptibility for biochemistry and genetic laboratory courses

Biochemistry and Molecular Biology Education

Volumn 37, Issue 4, 2009, Pages 236-242

  Soto Cruz, Isabel ^a   Legorreta Herrera, Martha ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Cancer; FTA cards; Genomic DNA; Mutation; P53; PCR; Polymorphism; Susceptibility

Indexed keywords

HEXAPODA;

EID: 69149099973     PISSN: 14708175     EISSN: None     Source Type: Journal    
DOI: 10.1002/bmb.20304     Document Type: Article

References (14)

1. S. Jin, A. J. Levin (2001) The p53 functional circuit, J. Cell Sci. 114, 4139-4140.
2. D. Malkin, K. W. Jolly, N. Barbier, A. T. Look, S. H. Friend, M. C. Gebhardt, T. I. Andersen. A. L. Borresen, F. P. Li, J. Garber (1992) Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms, N. Engl. J. Med. 326, 1309-1315.
3. M. Hollstein, D. Sidransky, B. Vogelstein, C. C. Harris (1991) p53 mutations in human cancers, Science 253, 49-53.
4. A. J. Levine, J. Momand, C. A. Finlay (1991) The p53 tumour suppressor gene, Nature 351, 453-456.
5. B. Vogelstein, D. Lane, A. J. Levine (2000) Surfing the p53 network, Nature 408, 307-310.
6. A. Helland, A. Langerod, H. Johnsen, A. O. Olsen, E. Skovlund, A. L. Borresen-Dale (1998) p 53 polymorphism and risk of cervical cancer, Nature 396, 530-531, author reply 532.
7. I. Zehbe, G. Voglino, F. Wilander, F. Genta, M. Tommasino (1999) Codon 72 polymorphism of p53 and its association with cervical cancer Lancet 354, 218-219.
8. A. Storey, M. Thomas, A. Kalita, C. Harwood, D. Gardiol, F. Mantovani, J. Breuer, I. M. Leigh, G. Matlashewski, L. Banks (1998) Role of a p53 polymorphism in the development of human papillomavirus-associated cancer, Nature 393, 229-234.
9. Y. C. Yang, C. L. Chang, M. L. Chen (2001) Effect of p53 polymorphism on the susceptibility of cervical cancer, Gynecol. Obstet. Invest. 51, 197-201.
10. A. N. Rosenthal, A. Ryan, R. M. Al-Jehani, A. Storey, C. A. Harwood, I. J. Jacobs (1998) p53 codon 72 polymorphism and risk of cervical cancer in UK, Lancet 352, 871-872.
11. T. Minaguchi, Y. Kanamori, M. Matsushima, H. Yoshikawa, Y. Taketani, Y. Nakamura (1998) No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection, Cancer Res. 58, 4585-4586.
12. J. W. Kim, J. W. Roh, N. H. Park, Y. S. Song, S. B. Kang, H. P. Lee(2001) Polymorphism of TP53 codon 72 and the risk of cervical cancer among Korean women, Am. J. Obstet. Gynecol. 184, 55-58.
13. W. Settheetham-Ishida, N. Kanjanavirojkul, C. Kularbkaew, T. Ishida (2005) Human papillomavirus genotypes and the p53 codon 72 polymorphism in cervical cancer Northeastern Thailand, Microbiol. Immunol. 49, 417-421.
14. J. Caceres-Cortes, J. A. Alvarado-Moreno, K. Waga, R. Rangel-Corona, A. Monroy-García, L. Rocha-Zavaleta, J. Urdiales-Ramos, B. Weiss-Steider, A. Haman, P. Hugo, R. Brousseau, T. Hong (2001) Implication of tyrosine kinase receptor and steel factor in cell density-dependent growth in cervical cancers and leukemias, Cancer Res. 61, 6281-6289.